{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=3", "query": { "intervention": "Protein Control", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 3497, "total_pages": 350, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Protein+Control&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T01:51:19.378Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06334133", "title": "Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "Cadisegliatin 800 mg QD", "type": "DRUG" }, { "name": "Cadisegliatin 800 mg BID", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "vTv Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2024-06-14", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 51, "location_summary": "Scottsdale, Arizona • Little Rock, Arkansas • Granada Hills, California + 44 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Granada Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Inglewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06334133" }, { "nct_id": "NCT00624065", "title": "Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "carvedilol controlled release/lisinopril", "type": "DRUG" }, { "name": "lisinopril + placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 348, "start_date": "2008-03", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 76, "location_summary": "Mobile, Alabama • Chandler, Arizona • Glendale, Arizona + 66 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Litchifield Park/Arizona", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624065" }, { "nct_id": "NCT01196936", "title": "Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Tamoxifen Citrate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Digital mammography", "type": "PROCEDURE" }, { "name": "immunohistochemistry staining method", "type": "OTHER" }, { "name": "pharmacological study", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "protein expression analysis", "type": "GENETIC" }, { "name": "pharmacogenomic studies", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "Fine needle aspiration", "type": "PROCEDURE" }, { "name": "Quality of Life Assessment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER", "GENETIC" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "FEMALE", "summary": "25 Years and older · Female only" }, "enrollment_count": 84, "start_date": "2010-09", "completion_date": "2028-12-11", "has_results": true, "last_update_posted_date": "2026-01-05", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Duarte, California • Aurora, Colorado + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01196936" }, { "nct_id": "NCT00525421", "title": "A Clinical Study of Curcuminoids in the Treatment of Oral Lichen Planus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oral Lichen Planus" ], "interventions": [ { "name": "Curcuminoids", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nita Chainani Wu", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 20, "start_date": "2007-10", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2013-08-07", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00525421" }, { "nct_id": "NCT00577577", "title": "Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myotonic Dystrophy Type 1" ], "interventions": [ { "name": "rhIGF-I/rhIGFBP-3", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Insmed Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 69, "start_date": "2007-12", "completion_date": "2008-12-29", "has_results": true, "last_update_posted_date": "2022-01-06", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 12, "location_summary": "Orange, California • Sacramento, California • Kansas City, Kansas + 9 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00577577" }, { "nct_id": "NCT02246764", "title": "Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "AR-13324 Ophthalmic Solution 0.02%", "type": "DRUG" }, { "name": "AR-13324 Ophthalmic Solution 0.02% BID", "type": "DRUG" }, { "name": "Timolol maleate Ophthalmic Solution 0.5% BID", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "19 Years to 99 Years" }, "enrollment_count": 93, "start_date": "2014-09", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-04-06", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 1, "location_summary": "Bedminster, New Jersey", "locations": [ { "city": "Bedminster", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02246764" }, { "nct_id": "NCT02464007", "title": "Study of rSIFN-co for Patients With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor" ], "interventions": [ { "name": "rSIFN-co", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sichuan Huiyang Life Science and Technology Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 7, "start_date": "2016-01", "completion_date": "2024-11", "has_results": false, "last_update_posted_date": "2025-02-25", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 4, "location_summary": "Phoenix, Arizona • Chicago, Illinois • Saint Paul, Minnesota", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02464007" }, { "nct_id": "NCT02334436", "title": "A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glabellar Frown Lines" ], "interventions": [ { "name": "Botulinum toxin, Type A", "type": "BIOLOGICAL" }, { "name": "0.9% sterile, unpreserved saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Evolus, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 324, "start_date": "2015-01", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2019-03-27", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 1, "location_summary": "Beverly Hills, California", "locations": [ { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02334436" }, { "nct_id": "NCT00177463", "title": "L-Carnosine for Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bipolar I Disorder" ], "interventions": [ { "name": "L-carnosine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 47, "start_date": "2004-09", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2016-01-11", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 3, "location_summary": "Bridgeville, Pennsylvania • McKeesport, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "Bridgeville", "state": "Pennsylvania" }, { "city": "McKeesport", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00177463" }, { "nct_id": "NCT06072547", "title": "Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cigarette Smoking Behavior" ], "interventions": [ { "name": "Access to all varieties of on! 4mg nicotine pouches (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original)", "type": "OTHER" }, { "name": "Access to Original on! 4mg nicotine pouches", "type": "OTHER" }, { "name": "Non-Flavored then complete flavor on! nicotine pouches", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Altria Client Services LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "22 Years to 65 Years" }, "enrollment_count": 400, "start_date": "2023-09-11", "completion_date": "2025-06", "has_results": false, "last_update_posted_date": "2024-07-11", "last_synced_at": "2026-10-22T01:51:19.378Z", "location_count": 1, "location_summary": "Raleigh, North Carolina", "locations": [ { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06072547" } ] }